Tower Research Capital (TRC)’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-200
| Closed | -$38 | – | 6116 |
|
|
2024
Q1 | $38 | Sell |
200
-2,247
| -92% | -$1.09K | ﹤0.01% | 5724 |
|
|
2023
Q4 | $2.75K | Buy |
2,447
+833
| +52% | +$1.19K | ﹤0.01% | 5170 |
|
|
2023
Q3 | $3K | Buy |
1,614
+1,541
| +2,111% | +$8.15K | ﹤0.01% | 5067 |
|
|
2023
Q2 | $516 | Hold |
73
| – | – | ﹤0.01% | 5609 |
|
|
2023
Q1 | $2K | Buy |
73
+20
| +38% | +$973 | ﹤0.01% | 5433 |
|
|
2022
Q4 | $3K | Buy |
53
+33
| +165% | +$4.75K | ﹤0.01% | 5269 |
|
|
2022
Q3 | $5K | Buy |
20
+7
| +54% | +$2.8K | ﹤0.01% | 5189 |
|
|
2022
Q2 | $6K | Buy |
13
+4
| +44% | +$2.2K | ﹤0.01% | 4987 |
|
|
2022
Q1 | $8K | Buy |
+9
| New | +$8.3K | ﹤0.01% | 4636 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | -$2K | – | 6704 |
|
|
2021
Q3 | $2K | Buy |
+1
| New | +$1.63K | ﹤0.01% | 5324 |
|
|
2021
Q1 | – | Sell |
-28
| Closed | -$29K | – | 5817 |
|
|
2020
Q4 | $29K | Buy |
28
+17
| +155% | +$13K | ﹤0.01% | 3607 |
|
|
2020
Q3 | $8K | Buy |
+11
| New | +$10.3K | ﹤0.01% | 4205 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$8K | – | 4446 |
|
|
2019
Q1 | $8K | Hold |
1
| – | – | ﹤0.01% | 2831 |
|
|
2018
Q4 | $1K | Buy |
+1
| New | +$3.23K | ﹤0.01% | 3696 |
|
|
2017
Q2 | – | Hold |
0
| – | -$3K | – | 3602 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 2515 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 2885 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$15K | – | 4622 |
|
|
2016
Q2 | $15K | Buy |
+1
| New | +$15.8K | ﹤0.01% | 2492 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3187 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4195 |
|
|
2015
Q3 | – | Hold |
0
| – | -$1K | – | 4941 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4109 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5047 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3751 |
|
|
2014
Q3 | – | Hold |
0
| – | -$6K | – | 4985 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 2759 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3697 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4995 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4361 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 2214 |
|
Other funds holding BIOL
Tower Research Capital (TRC)'s BIOL Position: Q2 2024 in Review
Tower Research Capital (TRC) sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 200 shares — an estimated $38 sold.
Tower Research Capital (TRC) first reported a position in BIOL in Q2 2016 and held it in 15 quarters. The position peaked at $29K in Q4 2020. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.
- Tower Research Capital (TRC) reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 200 Biolase, Inc. shares in Q2 2024, an estimated $38.
- Tower Research Capital (TRC) first reported a position in Biolase, Inc. in Q2 2016 and held it in 15 quarters.
- Tower Research Capital (TRC)'s Biolase, Inc. position peaked at $29K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.